DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Moore HB, Barrett CD, Moore EE. et al.
Is there a role for tissue plasminogen activator (tPA) as a novel treatment for refractory COVID-19 associated acute respiratory distress syndrome (ARDS)?.
J Trauma Acute Care Surg 2020; (e-pub ahead of print)
DOI: 10.1097/TA.0000000000002694.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.